Percentages of CD45RA+CD62L+T cells versus CD95− T cells in donors of different ages
Donors . | Age . | CD4+ Cells, % . | CD8+ Cells, % . | ||
---|---|---|---|---|---|
CD45RA+CD62L+ . | CD95− . | CD45RA+CD62L+ . | CD95− . | ||
RC | 18 | 77 | 77 | 42 | 42 |
CA | 20 | 51.3 | 52 | 30 | 30 |
SS | 21 | 60 | 60 | 41.8 | 41 |
MA | 59 | 52.7 | 53.2 | 45 | 45.5 |
MG | 59 | 55.7 | 55 | 35.9 | 34 |
DSM | 60 | 49.1 | 50.5 | 25.3 | 25 |
FM | 72 | 63 | 63 | 6.9 | 7 |
AG | 80 | 40 | 40 | 5.5 | 5.5 |
DMC | 99 | 21 | 20 | 3 | 3 |
MC | 100 | 39.1 | 38 | 8 | 7 |
Donors . | Age . | CD4+ Cells, % . | CD8+ Cells, % . | ||
---|---|---|---|---|---|
CD45RA+CD62L+ . | CD95− . | CD45RA+CD62L+ . | CD95− . | ||
RC | 18 | 77 | 77 | 42 | 42 |
CA | 20 | 51.3 | 52 | 30 | 30 |
SS | 21 | 60 | 60 | 41.8 | 41 |
MA | 59 | 52.7 | 53.2 | 45 | 45.5 |
MG | 59 | 55.7 | 55 | 35.9 | 34 |
DSM | 60 | 49.1 | 50.5 | 25.3 | 25 |
FM | 72 | 63 | 63 | 6.9 | 7 |
AG | 80 | 40 | 40 | 5.5 | 5.5 |
DMC | 99 | 21 | 20 | 3 | 3 |
MC | 100 | 39.1 | 38 | 8 | 7 |
The percentages of CD95− T cells were obtained by staining PBMCs with the following combinations of FITC-, PE-, and CyChrome-conjugated mAbs: CD95, CD4 or CD8, and CD3. The percentages of CD45RA+CD62L+ T cells were obtained by staining PBMCs with CD45RA, CD62L and CD4, or CD8 mAbs. Data from 10 donors, 18-100 years of age, are shown.